AI-Designed Obesity Drug Shows Over 31% Weight Loss

by Dr Natalie Singh - Health Editor
0 comments

Okay, here’s a revised and fact-checked version of the provided text, incorporating facts from web searches (as of today, February 15, 2024). I’ve corrected dates, added context, and clarified some points. I’ve also included a summary of the key findings.

## Insilico Medicine‘s ISM0676 Shows Promising Weight Loss Results in Preclinical Trials

![Efficacy-of-insilicos-ISM0676-Demonstrated-in-Mice-Model-777×525.jpg](https://scitechdaily.com/images/efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-777×525.jpg) 777w, [https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-400×271.jpg](https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-400×271.jpg) 400w, [https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-768×519.jpg](https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-768×519.jpg) 768w, [https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-150×101.jpg](https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-150×101.jpg) 150w, [https://scitechdaily.com/images/Efficacy-of-insilicos-ISM0676-Demonstrated-in-Mice-Model-450×304.jpg](https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model-450×304.jpg) 450w, [https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model.jpg](https://scitechdaily.com/images/Efficacy-of-Insilicos-ISM0676-Demonstrated-in-Mice-Model.jpg) 1075w” sizes=”(max-width: 777px) 100vw, 777px”/>

In diet-induced obese (DIO) humanized GIPR mice, ISM0676 treatment led to significant body weight reduction along with improved body composition, as indicated by a higher lean mass-to-body weight ratio. After 27 days of dosing, ISM0676 achieved a 10.4% reduction in body weight from baseline, compared to a 3% increase in the DIO vehicle group. Furthermore, when combined with Semaglutide, ISM0676 led to a substantially enhanced body weight loss of 31.3%.Credit: Insilico medicine

Insilico medicine,a company utilizing artificial intelligence for drug discovery,has announced promising preclinical results for its novel oral GIP receptor antagonist,ISM0676,in treating obesity. the compound demonstrated significant weight loss and improved body composition in mouse models, both as a standalone treatment and in combination with Semaglutide.

AI-Driven Drug Discovery

the discovery and optimization of ISM0676 were driven by Insilico’s Chemistry42 generative AI platform, along with tools like Alchemistry. Notably, the

Related Posts

Leave a Comment